International community meeting on drug pricing
2 April 2004. Related: Treatment access.
Treatment access
Global Fund halts $92 million grant for Ukraine after problems
2 April 2004. Related: Treatment access.
Global Fund says it needs $5 billion during 2004-2005
2 April 2004. Related: Treatment access.
South African minister of health in line to chair Global Fund
2 April 2004. Related: Treatment access.
Thai ddI patent case serves as example to other developing countries, Lancet viewpoint piece says
2 April 2004. Related: Treatment access.
UK gives £3 million to WHO’s ‘3 by 5’ treatment goal
2 April 2004. Related: Treatment access.
Global Fund awards bring total to $2.1bn and supply ARVs to 700,000 people
3 February 2004. Related: Treatment access.
Commentary: The Global Fund and treatment access in Latin America – a critical view
3 February 2004. Related: Treatment access.
Commentary: China starts long march against HIV
3 February 2004. Related: Treatment access.
WHO guidelines for use of ARVs in resource-poor settings
3 February 2004. Related: Treatment access.
Millions will benefit after GSK and BI license generic manufacturers to produce AZT, lamivudine and nevirapine
3 February 2004. Related: Treatment access.
Scaling up treatment access risks damaging national health systems, says WHO/UK report
3 February 2004. Related: Treatment access.
Access to treatment – some progress…
1 December 2003. Related: Treatment access.
WHO approves combination pills
1 December 2003. Related: Treatment access.
South African Competition Commission finds GSK and BI responsible for ‘excessive pricing’ and ‘abuse of market position’
1 December 2003. Related: Treatment access.
Access to HIV treatment in Eastern Europe
1 December 2003. Related: Treatment access.
Global AIDS spending must double by 2005, says gloomy UN
1 November 2003. Related: Treatment access.
GARPP requests permission from Boehringer to import generic nevirapine
1 November 2003. Related: Treatment access.
Canada decides to lead the way in exempting AIDS drugs from patent laws
1 November 2003. Related: Treatment access.
South Africa delays deregistering nevirapine
1 October 2003. Related: Treatment access.
Disagreement greets a new deal on patent protection and generic drugs for poor countries
1 October 2003. Related: Treatment access.
TRIPS agreement will not save lives
1 October 2003. Related: Treatment access.
Joint statement by 14 NGOs dismisses TRIPS deal as a ‘gift bound in red tape’
1 October 2003. Related: Treatment access.
An activist’s view from the WTO meeting in Cancun
1 October 2003. Related: Treatment access.
South African cabinet rules that public hospitals should provide ARVs
1 October 2003. Related: Treatment access.
Indian government taken to court over lack of treatment
1 October 2003. Related: Treatment access.
Township project is a model for care in resource poor settings
1 October 2003. Related: Conference reports, Treatment access.
Projects band together to buy lowest-cost generic drugs
1 October 2003. Related: Conference reports, Treatment access.
Facial fat loss – measuring and treatment
1 September 2003. Related: Conference reports, Treatment access, Weight, diabetes, metabolic complications.
Appointment of industry executive to supervise US AIDS initiative provokes criticism
1 September 2003. Related: Treatment access.
Activist anger over US ‘ambush’ of the Global Fund
1 July 2003. Related: Treatment access.
$15 billion AIDS bill signed, but full funding shaky
1 July 2003. Related: Treatment access.
New GAA report: US and G8 must act fast to rescue Global Fund
1 July 2003. Related: Treatment access.
World Health Assembly approves resolution supporting public health considerations in drug policy
1 July 2003. Related: Treatment access.
WHO Assembly analysis
1 July 2003. Related: Treatment access.
Bill Gates to give $1 million to Brazil’s AIDS programme
1 July 2003. Related: Treatment access.
Adherence is not a barrier to successful antiretroviral therapy in South Africa
1 July 2003. Related: Treatment access.
The impact of migration, race and ethnic diversity on healthcare delivery and clinical outcomes in the UK
1 June 2003. Related: Conference reports, Treatment access, Women's health.
Global Fund requires ‘significant’ new money
1 June 2003. Related: Treatment access.
Commentary: a crisis the Board must confront
1 June 2003. Related: Treatment access.
‘Fund the Fund’ launches campaign pack
1 June 2003. Related: Treatment access.
Senate approves Bush’s $15 billion international AIDS bill
1 June 2003. Related: Treatment access.
GSK halves drug prices to 63 countries
1 June 2003. Related: Treatment access.
Shareholders target PepsiCo over care for its employees in Africa
1 June 2003. Related: Treatment access.
Burkina Faso to purchase generic drugs from Indian company
1 June 2003. Related: Treatment access.
South Africa fails to accept $41 million from Global Fund
1 June 2003. Related: Treatment access.
UK gives £15.7m to Burmese HIV project
1 June 2003. Related: Treatment access.
Death of South African AIDS activist fuels anger
1 June 2003. Related: Treatment access.
The City turns up the heat on drug companies to make treatment available in poorest countries
1 May 2003. Related: Treatment access.
Lancet commentary concludes that prevention and treatment in South Africa are affordable and desirable
1 May 2003. Related: Treatment access.
South Africa treatment protests go global
1 May 2003. Related: Treatment access.
Gilead to sell tenofovir at cost to 68 countries
1 May 2003. Related: Treatment access.
New advocacy coalition demands emergency funding from rich governments for Global Fund
1 May 2003. Related: Treatment access.
NIH/NIAID study of generic drugs shows results consistent with stringent manufacturing standards
1 April 2003. Related: Conference reports, Antiretrovirals, Treatment access, PK and drug interactions.
Global Fund gives $210 million for treatment in Thailand
1 April 2003. Related: Treatment access.
Anti-HIV combination drug for Indonesia
1 April 2003. Related: Treatment access.
Indian generic drug maker Ranbaxy Laboratories to launch own-brand abacavir
1 April 2003. Related: Treatment access.
Bush blocks deal allowing cheap drugs
1 April 2003. Related: Treatment access.
Roche to sell nelfinavir, saquinavir at cost to least-developed nations
1 April 2003. Related: Treatment access.
South Africa appoints another dissident
1 April 2003. Related: Treatment access.
Bush plans $15 billion budget to treat two million people and prevent seven million infections in 14 countries – but meets criticism from activists
1 March 2003. Related: Treatment access.
The World Health Organisation must continue its work on access to medicines in developing countries
1 March 2003. Related: Treatment access.
Dr Jong-Wook Lee nominated to be WHO director-general
1 March 2003. Related: Treatment access.
AAI Pharma access programme providing treatment for 36,000 people in Africa
1 March 2003. Related: Treatment access.
Pharmacia to launch pilot programme for expanding access to medicines in the poorest countries
1 March 2003. Related: Treatment access.